Pabst Patent Group LLP is in the news – for seminars, events, lectures and more.
Atlanta, November 19, 2010 - Pabst Patent Group LLP (PPG) is pleased to announce that Robert A. Hodges, Ph.D. and David E. Huizenga, Ph.D., partners in the intellectual property group at Arnall Golden Gregory LLP (AGG) and formerly of Needle and Rosenberg, along with scientific advisors, Jonas Jarvholm, Ph.D., and Sandra A. Sciascia-Zirger, Ph.D., joined Pabst Patent Group effective November 16, 2010.
Drs. Hodges and Huizenga have extensive backgrounds in the fields of genetics, biochemistry, and biotechnology. Dr. Hodges has over 18 years of experience working in the patent field, particularly focusing on obtaining meaningful patent protection in biotechnology, molecular biology, and biomedicine. Dr. Huizenga's practice focuses on prosecuting biotechnology and pharmaceutical patents and advising on value creation paths for complex intellectual property portfolios in the life sciences field. They are bringing several significant clients with them.
"We are extremely pleased that Bob and David are joining our group and believe they will be instrumental in the further expansion of PPG" says Patrea L. Pabst, of Pabst Patent Group. "Bob and David began their patent law career with me and I am excited at this opportunity to work together with them again."
PPG specializes in intellectual property law in the life sciences, chemical, and medical device fields. The firm has continued to add patent professionals since its inception. This ongoing growth has facilitated the firm's representation of corporations, universities, start-ups and investors.
PPG is also pleased to announce that Michael J. Terapane, Ph.D. will become partner in 2011, joining founding partners Patrea Pabst and Rivka Monheit, and Charles Vorndran. Dr. Terapane has been with PPG since May 2004. Dr. Terapane's practice focuses on the chemical arts, especially pharmacetuicals, drug delivery technologies and consulting on generic versus brand name litigation.
Pabst Patent Group is an intellectual property law firm based in Atlanta, GA that specializes in biotechnology, pharmaceutical, and chemical patent law. The firm focuses on obtaining commercially meaningful intellectual property protection for its clients. Since its creation, the philosophy of the firm has been to provide superior intellectual property legal services at reasonable costs.